Journal article icon

Journal article

Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study

Abstract:
Study question: How safe is live attenuated influenza vaccine (LAIV), which contains egg protein, in young people with egg allergy? Methods: In this open label, phase IV intervention study, 779 young people (2-18 years) with egg allergy were recruited from 30 UK allergy centres and immunised with LAIV. The cohort included 270 (34.7%) young people with previous anaphylaxis to egg, of whom 157 (20.1%) had experienced respiratory and/or cardiovascular symptoms.... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1136/bmj.h6291

Authors


Expand authors...
More from this funder
Grant:
National Vaccine Evaluation Consortium, 039/0031
Publisher:
BMJ Publishing Group Publisher's website
Journal:
BMJ Journal website
Volume:
351
Pages:
Article: h6291
Publication date:
2015-01-01
DOI:
EISSN:
1756-1833
URN:
uuid:0094eee6-3cb2-406c-95ba-08a11e07d618
Source identifiers:
610249
Local pid:
pubs:610249

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP